Jon M Nakamoto
Overview
Explore the profile of Jon M Nakamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh I, Dowlin M, Chong T, Nakamoto J, Hilborne L
Arch Pathol Lab Med
. 2021 Mar;
145(7):821-824.
PMID: 33765119
Context.—: Coronavirus disease 2019 (COVID-19) changed the dynamics of health care delivery, shifting patient priorities and deferring care perceived as less urgent. Delayed or eliminated care may place patients at...
2.
Regelmann M, Kamboj M, Miller B, Nakamoto J, Sarafoglou K, Shah S, et al.
J Clin Endocrinol Metab
. 2018 Oct;
103(11):4324-4331.
PMID: 30289543
Context: Adrenoleukodystrophy (ALD) is a peroxisomal disorder associated with neurologic decompensation and adrenal insufficiency. Newborn screening for ALD has recently been implemented in five states with plans to expand to...
3.
Adgent M, Umbach D, Zemel B, Kelly A, Schall J, Ford E, et al.
J Clin Endocrinol Metab
. 2018 Mar;
103(5):1899-1909.
PMID: 29506126
Purpose: Chemicals with hormonelike activity, such as estrogenic isoflavones, may perturb human development. Infants exclusively fed soy-based formula are highly exposed to isoflavones, but their physiologic responses remain uncharacterized. Estrogen-responsive...
4.
Yun Y, Botelho J, Chandler D, Katayev A, Roberts W, Stanczyk F, et al.
Clin Chem
. 2012 Oct;
58(12):1703-10.
PMID: 23065474
Background: Testosterone measurements that are accurate, reliable, and comparable across methodologies are crucial to improving public health. Current US Food and Drug Administration-cleared testosterone assays have important limitations. We sought...
5.
Blatt A, Nakamoto J, Kaufman H
J Clin Endocrinol Metab
. 2011 Dec;
97(3):777-84.
PMID: 22170721
Context: Hypothyroidism, overt or subclinical, is associated with adverse outcomes for pregnant women and their offspring. Knowledge of current national thyroid testing rates and positivity during pregnancy is limited. Objective:...
6.
Blatt A, Nakamoto J, Kaufman H
Obstet Gynecol
. 2010 Dec;
117(1):61-68.
PMID: 21173645
Objective: To estimate the screening rate and prevalence of gestational diabetes mellitus (GDM) and the screening rate and prevalence of postpartum diabetes, in a large, national sample of pregnant women....
7.
Keen-Kim D, Redman J, Alanes R, Eachus M, Wilson R, New M, et al.
J Mol Diagn
. 2005 Apr;
7(2):236-46.
PMID: 15858147
Congenital adrenal hyperplasia is an autosomal recessive disorder caused by defective adrenal steroid biosynthesis, resulting in reduced glucocorticoid and increased androgen production. The majority of cases are due to inactivation...
8.
Pandian R, Nakamoto J
Clin Lab Med
. 2004 May;
24(1):141-74.
PMID: 15157561
No laboratory test has sufficient diagnostic sensitivity and specificity to serve as a gold standard for the diagnosis for GHD: therefore, test results must be interpreted after assessment of risk...
9.
Bastepe M, Frohlich L, Hendy G, Indridason O, Josse R, Koshiyama H, et al.
J Clin Invest
. 2003 Oct;
112(8):1255-63.
PMID: 14561710
Patients with pseudohypoparathyroidism type Ib (PHP-Ib) have hypocalcemia and hyperphosphatemia due to renal parathyroid hormone (PTH) resistance, but lack physical features of Albright hereditary osteodystrophy. PHP-Ib is thus distinct from...